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Abstract
Background: Chronic lymphocytic leukemia (CLL) was the predominant leukemia in a recent study of Chornobyl
cleanup workers from Ukraine exposed to radiation (UR-CLL). Radiation risks of CLL significantly increased with
increasing bone marrow radiation doses. Current analysis aimed to clarify whether the increased risks were due to
radiation or to genetic mutations in the Ukrainian population.
Methods: A detailed characterization of the genomic landscape was performed in a unique sample of 16 UR-CLL
patients and age- and sex-matched unexposed general population Ukrainian-CLL (UN-CLL) and Western-CLL (W-CLL)
patients (n = 28 and 100, respectively).
Results: Mutations in telomere-maintenance pathway genes POT1 and ATM were more frequent in UR-CLL compared
to UN-CLL and W-CLL (both p < 0.05). No significant enrichment in copy-number abnormalities at del13q14, del11q,
del17p or trisomy12 was identified in UR-CLL compared to other groups. Type of work performed in the Chornobyl
zone, age at exposure and at diagnosis, calendar time, and Rai stage were significant predictors of total genetic lesions
(all p < 0.05). Tumor telomere length was significantly longer in UR-CLL than in UN-CLL (p = 0.009) and was associated
with the POT1 mutation and survival.
Conclusions: No significant enrichment in copy-number abnormalities at CLL-associated genes was identified in UR-CLL
compared to other groups. The novel associations between radiation exposure, telomere maintenance and
CLL prognosis identified in this unique case series provide suggestive, though limited data and merit further
investigation.
Keywords: Ionizing radiation, Chronic lymphocytic leukemia, Mutation, Telomere, Chernobyl, Chornobyl
Background
Chronic lymphocytic leukemia (CLL) is the predominant
type of leukemia among males in Western populations
(30–40%) [1] and in Ukraine (> 50% in those 44 years and
older) [2]. Validated CLL risk factors include male sex,
longer telomere length, and several inherited genetic poly-
morphisms [3]. The clinical course of the disease is very
heterogeneous, ranging from indolent to aggressive and
rapidly progressive. Advances in microarray and sequen-
cing technologies have identified genetic biomarkers of
CLL as recurrent copy number abnormalities (CNAs), in-
cluding del13q14, del11q22–23, del17p, trisomy-12, and
frequent point mutations in SF3B1, NOTCH1, BIRC3 and
other genes [4]. Clinical characterization of these muta-
tions has identified del17p, TP53, and BIRC3 as markers
of high-risk CLL, and NOTCH1 and/or SF3B1 as markers
of intermediate risk [4].
It has been known, since the early 1950’s from the
Hiroshima and Nagasaki atomic bomb (A-bomb)
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survivors’ study, that radiation exposure may induce
most types of leukemia [5]. However, it generally has
been accepted that radiation does not induce CLL. Until
recently, the majority of epidemiological studies of occu-
pational, environmental, or therapeutic exposure to radi-
ation reported no excess risk of CLL [5]. Evidence
suggests that mortality-based studies could underesti-
mate, possibly substantially, CLL occurrence due to its
benign clinical course, thus incidence studies are needed
to characterize risks of low-dose radiation exposures [6].
Contrary to previous findings, recent incidence studies
from our group [7, 8], other groups studying occupa-
tionally exposed radiation workers [9, 10], as well as the
most recent update of the A-bomb incidence follow-up
study [11], albeit based on a small number (12) of cases,
reported significantly increased radiation risks of CLL.
In our recent study of the 1986 Chornobyl (Chernobyl)
nuclear accident, CLL was the predominant leukemia in
Ukrainian cleanup workers [7]. We reported signifi-
cantly increased risks of CLL with increasing bone mar-
row radiation doses, which could not be explained by
differences in lifestyle or environmental exposures [12].
Similar but statistically non-significant findings were
observed for Chornobyl cleanup workers from Belarus,
Russia and the Baltic countries [10]. Risk of CLL in
Russian Chornobyl cleanup workers was not elevated
[13], but questions have been raised about this analysis
based on the official reported doses and the Chornobyl
Registry-based leukemia diagnoses. Overall, there is
now an emerging consensus on the role of ionizing ra-
diation (IR) exposure in the etiology of CLL, but the
magnitude of risks remains unknown. Further studies
with large sample size of incident cases are warranted
to understand the effect of IR on CLL.
One of the main hypothesized mechanisms underlying
radiation-associated CLL is the absorption of energy from
IR by genetic material leading to genomic instability [14].
Although studies have reported deregulated gene expres-
sion in CLL specimens obtained in the post-Chornobyl
period [15], genetic characterization of Chornobyl-
associated CLL has not been previously performed. Chor-
nobyl cleanup workers present a unique opportunity to
study the relationship between IR exposure and the gen-
omic landscape of CLL after radiation. To better under-
stand the genetic architecture of radiation-associated CLL,
we performed comparative genomic analyses of Ukrainian
Chornobyl cleanup workers exposed to IR (UR-CLL) with
Ukrainian non-irradiated patients (UN-CLL) and Western
patients (W-CLL). Although the UR-CLL sample is small,
this is a unique series of confirmed CLL cases among
Chornobyl cleanup workers with individual radiation bone
marrow doses, confounder data and biological specimens.
To our knowledge, this is the first such study of CLL cases
after confirmed radiation exposures.
Methods
Patient recruitment
Cases of CLL among Chornobyl cleanup workers were ob-
tained from the Ukrainian-American Study of Leukemia
and Related Disorders among Chornobyl Cleanup
Workers from Ukraine [7]. Data on patient charac-
teristics and estimated doses were imported from the
original study [7]. Briefly, we previously conducted a
case-control study nested in a cohort of 110,645 male
Ukrainian workers who were 20–60 years of age during
cleanup activities in 1986–1990 after the Chornobyl nu-
clear power plant accident and who were registered in the
Chornobyl State Registry of Ukraine (SRU) before 1992
and resided in Kyiv City, or in any one of five study areas.
CLL cases diagnosed in the cohort during 20 years of
follow-up (1986–2006) were pathologically confirmed by
the International Hematology Panel consisting of five he-
matologists/ hematopathologists [16]. Bone marrow aspi-
rates/ biopsy slides and/or peripheral blood smears were
available for 70% of 79 confirmed CLL cases (UR-CLL)
with estimated bone marrow doses. Only 16 cases had suf-
ficient DNA for targeted next-generation sequencing
(≥100 ng).
Study samples for unexposed Ukrainian CLL (UN-CLL)
cases were from the patients treated at the National Re-
search Center for Radiation Medicine (NRCRM) in Kyiv,
Ukraine during 2002–2014. CLL diagnoses were con-
firmed by flow cytometry. From 119 available samples, we
randomly selected males of comparable age and matched
them to Chornobyl CLL cases in a ratio of 2:1. The final
sample included 28 samples with sufficient DNA for tar-
geted sequencing. An additional set of Western CLL (W-
CLL) patients included 100 non-overlapping patients from
the Dana Farber Cancer Institute (DFCI). To compare fre-
quency of gene mutations in Ukrainian and Western CLL
cases, exome sequencing data from DFCI patients was
downloaded from dbGAP (phs000435.v2.p1).
Patient characteristics
The following variables were examined for UR-CLL: the
latent period (interval of time in years between the date
of first exposure and the date of diagnosis of CLL)1; type
of work performed in the 30-km Chornobyl zone (early
responders, military personnel, professional nuclear
power workers, other); calendar year of CLL diagnosis;
time since first exposure; age at first exposure; age at
diagnosis; average frequency of visits to the doctor
prior to CLL diagnosis (zero, once every 2 years,
more than once every 2 years)2; and smoking and al-
cohol consumption.
DNA extraction and targeted sequencing
Blood smears for UN-CLL and UR-CLL cases were veri-
fied by study hematologists. Smears were scraped with
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scalpels (Miltex Inc., York, PA, USA) and DNA was ex-
tracted using QIAGEN QIAamp DNA Mini Kits (QIA-
GEN Inc., Valencia, CA, USA) as per manufacturer’s
instructions. The purity of the slides was ascertained by de-
termining the % of blasts. The average normal cell contam-
ination was estimated at 15% for UR-CLL and UN-CLL
slides. DNA concentration and quality were estimated by
picoGreen mitochondrial DNA stain (Life Technologies,
Carlsbad, CA, USA, Cat # P11495). CLL cases – 16 UR-
CLL and 28 UN-CLL – were selected for deep-sequencing
of cancer-relevant genes to discover novel driver muta-
tions. All UR-CLL and UN-CLL specimens were confirmed
to be pre-therapy to eliminate any therapy-induced effect.
For targeted deep sequencing (TDS), SeqCap EZ Ex-
ome Probes v3.0 (Roche Sequencing Solutions, Madison,
WI, USA) were used to capture exonic regions of 538
genes included in the “UCSF500 Cancer Gene Panel”
(Additional file 1: Table S1). Paired-end libraries were
generated as per KAPA DNA Library Kits (Kapa Biosys-
tems, Wilmington, MA, USA). DNA samples were bar-
coded and pooled for multiplexed sequencing on the
Illumina HiSeq 2500 platform, which was run in Rapid
run mode to obtain 130 million reads per lane. Sixteen
samples were multiplexed with Illumina indexes and run
per lane. On average, 80% of reads were retained after
duplicate filtering, less than 3% were unmappable, and
the remaining 17% of the reads were mapped to off-
target regions. About 70% of the reads were mapped to
target and near target areas of the bait.
Raw primary sequence data (.bam files) for W-CLL
cases were re-aligned and mutations were called within
the same genomic-capture regions as for the UCSF500
Cancer Gene Panel.
For data analysis, initial alignment of paired-end se-
quencing reads to the human reference genome (UCSC
version hg19) was performed using the Burrows-Wheeler
Aligner (BWA version 0.7.10-r789), with reads sorted by
position and converted to compressed BAM format using
SAM tools. Likely PCR and optical duplicate read pairs
were marked using Picard (version 1.97(1504)). Insertion
and deletion (INDEL) realignment and recalibration
were carried out using the Genome Analysis Toolkit
(GATK) (http://www.broadinstitute.org/gsa/wiki/index.
php/The_Genome_Analysis_Toolkit). Single nucleotide
variants (SNVs) and small sequence INDELs were called
in each sample using the GATK command “Unified Geno-
typer”, with variant calls stored in VCF files.
Variant calls with total read depth less than 10X were
excluded from further analysis for the lack of confidence
in true variant calling. In the absence of matched normal
sample from each tumor, to exclude likely germline poly-
morphisms we filtered out variants present in dbSNP or
with a minor allele frequency > 0.01% in the Exome Ag-
gregation Consortium (ExAC) Database. Coding variants
predicted to affect protein sequence (e.g., nonsynon-
ymous, stop gain, splicing) were analyzed further. To pre-
dict deleterious effects of variants, we used Polyphen,
SIFT and Combined Annotation Dependent Depletion
(CADD) tool version 1.3 (http://cadd.gs.washington.
edu/score), which integrates information from multiple
functional annotation tools into a single score. Finally,
nonsynonymous variants of significant interest were visu-
ally inspected using the Integrated Genomics
Viewer (http://software.broadinstitute.org/software/igv/).
Copy number analysis
CNAs were analyzed using CNVkit [17] and off-target
reads from the target area with capture probes. CNVkit
was run with default parameters and female genome as ref-
erence. A threshold of 0.3 was applied to identify the signals
for amplification and deletions of the genomic segments.
Mutation and CNA prevalence calculation
Mutation and CNA prevalence was calculated as percent of
cases harboring nonsynonymous mutations or copy num-
ber changes in a specific gene within a particular sample.
Telomere length estimation
The telomere length was estimated by using off-target
reads mapping to TTAGGG telomeric repeats, which has
been shown to correlate with Southern blot measure-
ments of the mean length of terminal restriction frag-
ments (mTRFs) [18].
NMF signature analysis
A non-negative matrix factorization (NMF) [19] was
used to identify a radiation-associated mutational signa-
ture in exposed and unexposed Ukrainian CLL patients.
Bone marrow dose estimation for exposed CLL cases
(UR-CLL)
A time-and-motion method of retrospective dose recon-
struction in cleanup workers, known as RADRUE, was de-
veloped for the study of cleanup workers from Ukraine
[20, 21] and for a similar study conducted in Belarus,
Russia, and Baltic countries [10] by an international group
of scientists including experts from Belarus, France,
Russia, the United States, and Ukraine. The method used
combined data on work history from dosimetric question-
naires with field radioactivity measurements to estimate
individual bone marrow doses for all study subjects. In-
person interviews were conducted by trained interviewers
and included questions concerning locations of work and
residence while in the 30-km exclusion zone around the
Chornobyl nuclear power plant, types of work, transporta-
tion routes, and corresponding dates. For deceased CLL
cases, proxy interviews were conducted with next-of kin
for demographic and medical information and with co-
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workers for work histories in the 30-km exclusion zone
[21]. Additional validation studies have shown that bone
marrow radiation dose estimates based on information
from proxies were comparable to those based on direct in-
terviews [22].
Statistical methods
All analyses relied on cumulative radiation doses derived
as the sums of the arithmetic means of the annual
1986–1990 bone marrow doses estimated by generating
10,000 realizations of dose predictions from
the RADRUE method as described above.
Univariate tests of normally distributed continuous
variables were performed using one-way analysis of vari-
ance (ANOVA), and on non-normally distributed vari-
ables using a Wilcoxon– Mann–Whitney test. Additional
multivariate analyses were conducted using Poisson re-
gression for genetic lesions, total number of genetic le-
sions and mutations and telomere length, and using
logistic regression for POT1 mutations, and included cat-
egorical as well as continuous predictors.
All p-values presented were two-sided. The best fitting
models were chosen by using the likelihood ratio test
and Akaike Information Criterion. All analyses were
conducted using the SAS 9.4 software (SAS Institute,
Cary, NC, USA).
Results
This analysis is based on the 16 cases who had sufficient
DNA for targeted next-generation sequencing drawn
from the parent study of 79 CLL cases from the Ukrainian-
American Study of Leukemia and Related Disorders
among Chornobyl Cleanup Workers from Ukraine [7]. Se-
lected cases did not differ from all cases in terms of age at
first exposure, age at CLL diagnosis or radiation dose (all
p > 0.1, not shown).
UR-CLL and UN-CLL samples were sequenced to
~450X depth and compared to W-CLL. Total numbers of
nonsynonymous point mutations across the 538 cancer-
relevant genes were comparable in UR-CLL (range 2–12,
median 8), UN-CLL (range 2–12, median 8), and W-CLL
(range 2–11, median 8) samples. CADD Phred scores in-
dicated no statistically significant difference in deleterious-
ness of detected mutations across the three groups.
We further analyzed the correlation of genetic lesions
(total number of mutations + CNAs) with several clinical
variables (Table 1) and bone marrow radiation dose (me-
dian: 40.56 milligray (mGy); range: 0.24–1536.24 mGy).
The type of work performed in the 30-km Chornobyl
zone, age at first exposure, age at diagnosis, calendar time
and Rai stage of CLL were identified as significant predic-
tors of genetic lesions (all p < 0.05), together explaining
20% of their variability (combined pseudoR2 = 0.20).
Adjusting for all other factors, Chornobyl CLL patients
who had more advanced stage at diagnosis (Rai stage ≥2)
had a two-fold higher predicted number of total lesions
compared to those diagnosed at a less advanced stage.
We compared the prevalence of putative CLL driver
mutations across three samples, and NOTCH1 was the
most frequently mutated gene overall and was mutated
at similar frequencies across the three samples (Fig. 1a).
POT1 was the most frequently mutated gene in UR-CLL
(25%), followed by NOTCH1, RB1 (19% each), ATM,
APC, MED12, SF3B1, and KMT2C (13% each) (Fig. 1a
and Additional file 1: Table S2). The most common
CNAs identified in UR-CLL were del13q14 and del11q
(12% each) (Additional file 1: Table S3). No statistically
significant differences were identified in frequencies of
CNAs between UR-CLL, UN-CLL and W-CLL.
To further delineate genomic differences between
radiation-associated CLL and idiopathic CLL, an NMF
approach [19] was applied. UN-CLL tumors were
enriched for mutations in genes with roles in epigen-
etic regulation (EP300, ARID1B, ZMYM3, KMT2C) and
the Ras/MAPK signaling pathway (FLT4, MET, EPHA7,
MAP3K1), consistent with previous studies (Fig. 1b) [23].
We searched for a potential radiation-associated muta-
tional signature in UR-CLL, but a specific pattern of pre-
ferred nucleotide substitutions could not be resolved.
Next, we performed pathway analyses and identified mu-
tations in telomere-maintenance pathway genes to be
enriched in UR-CLL. We observed a significantly higher
frequency of POT1 mutations in UR-CLL compared to
both the UN-CLL and W-CLL cases ( p = 0.03 and 0.009,
respectively). Further, recurrent mutations were found in
ATM, RB1, and MED12 in UR-CLL (Fig. 1b). All 4 POT1
mutations detected in UR-CLL were localized to OB-fold
domains 1 & 2 (Fig. 2a), while recurrent ATM mutations
were localized to other functional domains (Fig. 2b).
Since POT1 haploin sufficiency has been reported to
cause telomere elongation in CLL and glioma [24], we
estimated telomere length via telseq [18] and identified a
significantly longer age-adjusted mean telomere length
in UR-CLL tumors compared with UN-CLL (Table 1
and p = 0.009 in Fig. 2c).
We further analyzed telomere length correlation with
other covariates and identified lifestyle factors such as al-
cohol consumption, smoking and type of cleanup work
performed in the Chornobyl zone as significant predic-
tors of tumor telomere length in UR-CLL (combined
R2 = 0.63). In a combined analysis of telomere length
among UR-CLL and UN-CLL groups, age was not a
predictor of tumor telomere length (p = 0.17) whereas
exposure to radiation was a significant and strong pre-
dictor (1.59 unit increase in length due to radiation
(95% confidence interval: 0.64, 2.55, p < 0.01)). In total,
IR explained 20% of the variability in telomere length.
As POT1 and MED12 mutations have been previously
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associated with poor prognosis in CLL patients [24, 25],
we tested the trend of median survival of the 4 POT1-
mutated UR-CLL cases. Results were not significantly
different from the other UR-CLL cases, but a trend was
observed indicating better prognosis of POT1 mutation
bearing-cases (median 5.3 years vs. 3.6 years, POT1-
mutated vs. other UR-CLL cases, p = 0.74).
Discussion
This study was conducted to understand the effect of IR
on CLL development and progression in a series of
high-quality DNA specimens with corresponding radi-
ation dosimetry and clinical information. Radiation ex-
posure arose from a ‘natural experiment’ (i.e., an
individual’s exposure status was determined by outside
forces but resembled random assignment). To our
knowledge, this is the first study of genetic characteris-
tics of CLL specimens in relation to individual radiation
doses. Unfortunately, we could not perform this study
on a larger sample set, and therefore the findings de-
scribed here should be treated as a valuable case-series
with unique preliminary and valuable data for guiding
future research hypotheses.
Absence of statistically significant differences in fre-
quencies of CNAs between UR-CLL, UN-CLL, and
W-CLL indicated a similar genomic architecture in
radiation-exposed compared with unexposed cases, and in
Ukrainian and Western cases.
Sherborne et al. identified mutation signature signifi-
cantly associated with high-dose (total dose of 30 Gy) IR in
multiple IR-induced malignancies [19]. We used their non-
negative matrix factorization technique to identify IR-
associated mutation signatures above genetic background
in UR-CLL. Specific pattern of preferred nucleotide substi-
tutions, associated with IR exposure could not be resolved
in mutations accumulated and identified in UR-CLL. This
suggests that protracted exposure to low-dose radiation did
not appear to induce widespread genomic changes via a
specific mutational mechanism. However, our study might
be underpowered to detect such a signature due to an in-
sufficient number of mutations observed per case or the
relatively low bone marrow doses estimated for UR-CLL
Table 1 Characteristics of Ukrainian CLL cases
Variable Exposed (UR-CLL)a Unexposed (UN-CLL)b
Cases, N 16 28
Age at diagnosis, median (range), years 61 (49–78) 58 (41–76)
Sex Male Male
Diagnosis year, range 1986–2006 2002–2014
Blood count, median (range), 10 × 9 per mL 13 (2–55) 54 (16–122)





Smoking history, n (%) NaNc
never or former 9 (56)
less than 20 cigarettes/day 5 (31)
20 or more cigarettes/day 2 (13)
Alcohol consumption NaNc
never 4 (25)
no more than 2–3 times a month 7 (44)
once a week or more 5 (31)
Bone marrow radiation dose, median (range), milligray (mGy) 40.56 (0.24–1536.24) NAd
POT1 mutation, n (%) 4 (25) 0 (0)
Telomere length, median (range), kilobytes (kb) 1.58 (0.12–9.06) 0.30 (0.09–2.47)
Survival after diagnosis, median (range), years 4 (1–18) NaNc
Based on 15 cases who have died by the end of follow-up
aCLL cases in Chornobyl cleanup workers from Ukraine exposed to ionizing gamma-ray radiation
bSex- and age-matched CLL cases from the general population of Ukraine unexposed to ionizing radiation
cNaN = Not Available
dNA = Not Applicable
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patients. Low bone marrow doses of UR-CLL might
also explain the lack of expected genomic instability.
We identified enrichment of mutations in genes with
roles in epigenetic regulation (EP300, ARID1B, ZMYM3,
KMT2C) and the Ras/MAPK signaling pathway (FLT4,
MET, EPHA7, MAP3K1), consistent with previous
studies [23].
Although we did not identify a radiation-associated
mutation signature in UR-CLL cases, our pathway ana-
lyses did reveal an enrichment of mutations in telomere-
maintenance genes. POT1, ATM, and RB1 all have re-
ported roles in telomere maintenance [26]. The most
frequently mutated gene in UR-CLL was POT1 (Protec-
tion of Telomeres 1), and it was mutated at significantly
higher frequency than in UN-CLL or W-CLL. POT1 is
one of six members of shelterin, a protein complex that
binds telomeres. Additional shelterin complex proteins
are encoded by TERF1, TERF2, TINF2, TERF2IP, and
ACD. Three shelterin subunit proteins, including POT1,
directly bind to the telomeric hexanucleotide repeats
[27]. Previous studies have shown that localization of
mutant POT1 protein to the telomere causes dominant-
negative telomere lengthening and telomere uncapping,
leading to unprotected telomere ends and chromosomal
fusions in CLL tumors [24]. Interestingly, all 4 POT1
mutations detected in UR-CLL lie in OB-fold domains 1
& 2, which interacts with telomeric DNA and provides
specific binding to various ligands [28]. These results
suggest that we have identified functional POT1 muta-
tions likely to be involved in telomere uncapping and
telomere lengthening. Similarly, recurrent ATM muta-
tions that we identified were also localized in functional
a
b
Fig. 1 Genomic landscape of CLL cases. (a) Prevalence of driver mutations, as defined in Landau et al. [23] in Western-CLL (dbGaP/Western; W-
CLL cases from previous sequencing studies, light gray bars), Chornobyl cleanup workers with CLL (Exposed; UR-CLL, black bars) and unexposed
Ukrainian CLL cases (UnExpsed; UN-CLL, gray bars). The asterisks identify significant comparisons (p < 0.05); (b) Tiling plot of predicted damaging muta-
tions in exposed (UR-CLL) and unexposed (UN-CLL) Ukrainian patients. Horizontal rows depict mutations in a particular gene and functional category,
and vertical columns represent individual patients (exposed and unexposed). Patients without mutations were excluded from the figure. Mutations are
shaded according to their mutant allele fraction (MAF)
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domains. Although no direct association of MED12 has
been identified with telomere biology, MED12 mutations
in association with TERT promoter mutations and in-
creased telomere length have been reported in different
tumors [29].
Previous studies suggest that radiation exposure is as-
sociated with telomere attrition [30], especially in males.
However, studies of Chornobyl cleanup workers reported
associations between longer telomere length and in-
creased cancer diagnoses [31]. This is particularly com-
pelling for CLL, as recent studies have established
longer telomere length in healthy lymphocytes as a risk
factor for future development of CLL [32, 33]. Our ob-
servation that radiation exposure was associated with
longer telomere length in UR-CLL tumors suggests that
pre-malignant B-cells in radiation-exposed men may be
under strong selective pressure to circumvent growth ar-
rest caused by telomere attrition. Somatic cells can
undergo a host of different genetic and epigenetic mech-
anisms to lengthen telomeres, including reactivation of
telomerase or alternative lengthening of telomeres
(ALT). The observed frequency of POT1 mutations in
UR-CLL (25%) is much higher than in recent studies of
radiation-unexposed CLL patients (3.5% to 9% [24]).
Our observation that UR-CLL patients were likelier to
harbor mutations in telomere-maintenance genes fits
this proposed model.
Although survival of UR-CLL patients with POT1 mu-
tation was longer compared to other UR-CLL patients,
this finding was based on a small number of cases and
should be examined in future studies. Follow-up of all
79 CLL cases diagnosed in the Ukrainian-American
Study of Leukemia and Related Disorders among Chor-
nobyl Cleanup Workers from Ukraine indicated median
overall survival of 4.8 years (range 0.5–19.5, 5-year sur-
vival rate of 46.2%) [8]. This is substantially lower than
survival of U.S. CLL patients from the SEER database
(5-year survival rate of 83.2%) [34].
Although the incidence of CLL is substantially higher
in Ukraine than in Western countries, we observed a
great deal of similarity between the somatic genomes of
UN-CLL cases and W-CLL cases. Both groups had fre-
quent mutations in NOTCH1, had similar CNA profiles,
and were enriched for mutations in genes with roles in
epigenetic regulation and the Ras/MAPK signaling path-
way. These data suggest that there is a similar somatic
genomic architecture in non-irradiated Ukrainian CLL




Fig. 2 Telomere length comparison and associated mutations (a) Location and type of mutations associated with telomere maintenance
pathway genes POT1 and (b) ATM. (c) Boxplot of estimated telomere length between exposed (UC-CLL) and unexposed (UN-CLL) Ukrainian
samples. Fifty percent of the data is within the box, 75% within the whiskers, and outliers are noted by circles. A black line within the box depicts
the median telomere length for the group
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differences in incidence rates of CLL across these groups
may be attributable to other factors, such as the fre-
quency of heritable genetic variants or the prevalence of
other environmental risk factors.
Conclusions
We conducted a comprehensive three-way comparison of
UR-CLL, UN-CLL and W-CLL to understand the rela-
tionship of IR with CLL etiology. Ukrainian CLL patients
with no history of radiation exposures had similar somatic
genomic architecture to Western CLL patients. Our ana-
lysis of CLL patients exposed to IR due to clean up work
after the Chornobyl accident suggests that dose to the
bone marrow is correlated with an increase in burden of
driver lesions in a dose-dependent manner. Further, longer
telomere length in tumors and mutations in telomere-
maintenance genes indicate a potential role for telomere
biology in the genesis of radiation-associated CLL. No
other mutations were found in genes clinically associated
with chemorefractoriness or affecting survival. Future ana-
lyses of larger patient sets in radiation-associated cancer
types can help bolster these findings. To our knowledge,
this is the first study to perform an in-depth genomic
characterization of CLL in Chornobyl cleanup workers,
highlighting a potentially important role for telomere biol-
ogy in leukemogenesis.
Endnotes
1The date of diagnosis for each individual is the first
date recorded when the absolute number of lymphocytes
in the peripheral blood exceeded 5000/μL.
2All cleanup workers registered in the State Chornobyl
Registry were eligible for an annual health examination,
which included a differential blood count and consult-
ation with a physician. These examinations usually were
conducted at a regional health facility.
Additional file
Additional file 1: Table S1. List of target genes sequenced by targeted
deep sequencing. Table S2. Mutations in Exposed and Unexposed Cases.
Table S3. Copy Number Aberrations (CNA) in Exposed and Unexposed
Cases. (DOCX 311 kb)
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